The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective | Nature Communications
Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications
Payload distribution and capacity of mRNA lipid nanoparticles | Nature Communications
High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury | Nature Communications
A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology
The Time and Place for Nature in Drug Discovery | JACS Au
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery
A critical evaluation of methods to interpret drug combinations | Scientific Reports
Why 90% of clinical drug development fails and how to improve it? - ScienceDirect
Effective drug combinations in breast, colon and pancreatic cancer cells | Nature
Synergistic drug combinations tend to improve therapeutically relevant selectivity | Nature Biotechnology
Proteome-wide covalent ligand discovery in native biological systems | Nature
Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets | Nature Communications
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications
Neural circuit dynamics of drug-context associative learning in the mouse hippocampus | Nature Communications
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety | Chemical Research in Toxicology
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications
Normalizing and denoising protein expression data from droplet-based single cell profiling | Nature Communications
Designing hydrogels for controlled drug delivery | Nature Reviews Materials
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature
A critical evaluation of methods to interpret drug combinations | Scientific Reports
